Infection Surveillance Solutions Market

Report Overview

The global Infection Surveillance Solutions Market size is expected to be worth around USD 2026.59 million by 2032 from USD 514.2 million in 2022, growing at a CAGR of 14.7% during the forecast period 2022 to 2032.

The primary trends driving the market growth are the rising prevalence of hospital-acquired infection (HAIs), increasing resistance to antibiotics, and the growing use of automation within healthcare settings. The market’s growth can be impeded by the high price of these solutions and the shortage of qualified healthcare IT professionals.

Market Dynamics:

The Centers for Disease Control and Prevention (CDC) estimates that drug-resistant bacteria cause more than 23,000 deaths each year and make approximately 2.0 million Americans sick. According to statistics from the European Commission (EC), approximately 25,000 people are killed each year in Europe by antibiotic-resistant bacteria. It is expected that 10 million people will die each year if the current trend in infection continues through 2050.

The number of global surgeries has increased, which has resulted in more hospital stays. The number of HAI-affected patients is expected to rise. This will be a positive for the market. The market will also be affected by rising healthcare expenditures.

The market has also grown because of favorable government initiatives. Canada’s National Microbiology Laboratory (NML), and the Canadian Public Health Agency of Canada’s Centre for Communicable Diseases and Infection Controls (CCDIC) created the Canadian Nosocomial Infection Surveillance Program to track trends and provide information on HAIs in Canadian healthcare facilities. CNISP currently has 54 participating hospitals.

Drivers

The rising incidence of HAIs around the globe is one of the main drivers of market demand for infection surveillance software. HAIs are caused by a decrease in immunity, decreased effects of ongoing medication, poor hygiene, higher healthcare costs, and negligence. HAIs are a major cause of death in healthcare settings. This is why many healthcare center facilities have adopted infection surveillance technologies to improve their infection control strategies and processes. Continuous monitoring and management of HAI data are possible through infection surveillance. This allows for early detection and assessment of diseases and the execution of preventative measures.

Trends and Opportunities

Infection surveillance solutions market, the key trends are the shift in preference of healthcare professionals towards automation and the growing demand for mobile platforms and web-based solutions. The market will be able to offer wide opportunities to players due to the increasing adoption of infection surveillance in emerging countries in Latin America and Asia-Pacific, as well as cloud-based software.

Restraints

The market for global infection surveillance software is likely to slow down due to insufficient data management and inadequate computing resources. Inadequate data management can lead to inaccurate and insufficient data about patients’ medical history, care, and treatment. This results in insufficient or incorrect inferences for surveillance systems.

Market growth will also be impeded by the high cost of infection surveillance systems.

Global Infection Surveillance Solutions Market Scope:

Product type analysis

Based on product and service, the market is segmented into services and software. Web-based and on-premise software make up the second division of the software market. In 2021, the market was dominated by the software sector. Due to a higher adoption of software packages by healthcare institutions, the services segment will exhibit a higher CAGR during the projection period.

Over the predicted period, web-based software will have the highest CAGR. Compared to conventional on-premise software, this sub-appeal segment’s has grown quickly. Additionally, it provides flexibility, real-time analysis, and a quicker return on investment. Healthcare IT businesses also develop cutting-edge infrastructure, analytics, and data management systems that make it more simpler to collect data from electronic health records (EHRs), infections, and epidemic trends.

Type analysis

Surgical site infections, bloodstream infections (BSI), bladder infections (UTI), and other infections have been segmented in the market for infection surveillance solutions. UTI dominated this market in 2021. Up to 2032, this market is anticipated to continue to rule. The other segment, which includes bacteria that resist antibiotics and organisms that cause pneumonia, is anticipated to grow at an impressive rate over the projection period.

According to womenshealth.gov, women have a 30.5 percent higher risk of developing UTIs than males do. The CDC reports that extended catheter use is to blame for 75,5 percent of UTIs in hospitals. Additionally, according to the European Centre for Disease Prevention and Control, 3.5% of patients kept in the intensive care unit for longer than two days had UTIs.

End-use analysis

Depending on the market’s ultimate use, hospitals and long-term care facilities might be distinguished. In 2021, hospitals contributed the most money globally. Compared to other entities, hospitals have a greater percentage of HAIs. This is because they can handle patients more effectively and devote more

Hospitals deploy electronic surveillance devices in about 45.5 percent of cases. As more software tools are required for a quicker study of illness patterns, this number is anticipated to increase. By examining historical infection trends with modelling techniques, automated technologies assist in limiting disease epidemics.

Кеу Маrkеt Ѕеgmеntѕ

By Product type

• Software
  • On-premise
  • Web-based
• Services

By Type

• Surgical Site Infections (SSI)
• Blood Stream Infections (BSI)
• Urinary Tract Infections (UTI)
• Others

By End-use

• Long-Term Care Facilities
• Hospitals
• Others (Clinics, and Ambulatory Surgical Centers)

Regional Analysis

Through 2032, North America will be followed by Europe. The growth of the regional market will be fueled by strong government initiatives and rising HAI incidences in Canada and the U.S. For instance, the National Action Plan (NAP), a five-year action plan, was introduced to combat antibiotic-resistant bacteria, including the incidence of Carbapenem-resistant Enterobacteriaceae, Clostridium difficile, and methicillin-resistant Staphylococcus aureus.

Due to the growing demand for medical tourism and improved healthcare infrastructure, the Asia Pacific market will experience significant growth over the forecast period. The market’s growth is impeded by the high cost of advanced systems and the lack of awareness about their availability.

Key Regions and Countries covered іn thе rероrt:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Russia
  • Spain
  • Rest of Europe
• APAC
  • China
  • Japan
  • South Korea
  • India
  • Rest of Asia-Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• MEA
• • GCC
  • South Africa
  • Israel
  • Rest of MEA

Market Share & Key Players Analysis:

Becton, Dickinson and Company, Premier Inc., Wolters Kluwer N.V., Gojo Industries, RL Solutions, Baxter International Inc., Premier Inc., Deb Group Ltd, and Truven Health Analytics (an IBM Company) are some of the most prominent companies in the market. These companies are focused on the launch and expansion of new products. Wolters Kluwer’s new clinical terms surveillance solution Sentri7 was launched in September 2018. This tool allows hospitals to monitor for infection and limit the spread of antibiotic-resistant bacteria.

Маrkеt Кеу Рlауеrѕ:

• Becton, Dickinson
• Premier Inc.
• PeraHealth Inc.
• Wolters Kluwer N.V.
• Gojo Industries Inc.
• RadicaLogic Technologies, Inc.
• Baxter International Inc
• Other Key Players

For the Infection Surveillance Solutions Market research study, the following years have been considered to estimate the market size: